Intrasense (ALINS.PA) Stock Price
Intrasense Price
Over the last 17 years Intrasense grew revenue by 3.9% annually, reaching 2.96 M EUR. For Intrasense, the net margin of -364.8% is down versus -28.7% a few years ago. The consensus 12-month price target for Intrasense is 0.24 EUR, about 19.4% above where the stock trades today. Of 7 analysts, 0 rate the stock a buy — an overall Sell consensus.
Intrasense stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Intrasense business model & stock analysis
Frequently asked questions about Intrasense
The business model of Intrasense SA focuses on providing innovative medical imaging software solutions. Intrasense SA develops and commercializes advanced imaging software products, which enable healthcare professionals to optimize and streamline their diagnostic processes. By leveraging cutting-edge technologies, such as machine learning and artificial intelligence, Intrasense SA's software solutions improve the accuracy, efficiency, and decision-making capabilities in medical imaging, ultimately benefiting patients and healthcare providers. Intrasense SA's dedication to continuous research and development ensures that their software remains at the forefront of medical imaging technology, solidifying their position as a leader in the industry.
Intrasense SA is primarily active in the healthcare and medical imaging industries.
The main competitors of Intrasense SA in the market are companies like GE Healthcare, Siemens Healthineers, and Philips Healthcare. These global leaders in the medical imaging field provide similar products and services as Intrasense SA, including advanced imaging software solutions for healthcare institutions. Intrasense SA competes by offering innovative technologies and solutions that deliver accurate and efficient medical imaging diagnosis. By constantly advancing their product portfolio and maintaining superior customer service, Intrasense SA aims to stay competitive in the market against these industry giants.
Intrasense SA, a leading medical imaging software company, has a rich history and background. Founded in 2004, the French-based company specializes in providing innovative solutions for the management and analysis of medical images. Intrasense has developed a comprehensive suite of software products, including Myrian®, a fully integrated platform that enables efficient image visualization and analysis. With a focus on improving patient care and clinical decision-making, Intrasense has established a strong presence in the global healthcare industry. The company continues to strive for advancements in medical imaging technology, aiming to provide healthcare professionals with cutting-edge tools to enhance diagnostic accuracy and improve patient outcomes.
Intrasense SA has achieved several significant milestones in its history. The company pioneered innovative medical imaging technology, which has revolutionized the healthcare industry. Intrasense SA introduced its flagship product, Myrian®, an advanced multi-modality imaging platform that offers comprehensive and efficient image analysis for healthcare professionals. Moreover, the company has successfully expanded its global presence by establishing strategic partnerships with leading medical equipment manufacturers and healthcare providers. Intrasense SA's consistent research and development efforts have resulted in continuous product advancements, ensuring its position as a market leader in medical imaging solutions. These milestones highlight the company's commitment to delivering cutting-edge technologies and improving patient care worldwide.
Intrasense SA is primarily present in France, as it is a French company. It is headquartered in Montpellier, France and has operations throughout the country. However, as an international company, Intrasense SA also has a global presence with a focus on Europe, Asia, and the Americas. It has subsidiaries and partnerships in several countries, including Germany, Spain, the United States, China, and Brazil. Intrasense SA aims to expand its presence in key markets worldwide, providing innovative medical imaging software solutions to healthcare institutions and professionals.
Intrasense SA represents a set of core values and a corporate philosophy that guide its operations. The company aims to provide innovative medical imaging solutions and advanced software for healthcare professionals. Intrasense SA is dedicated to enhancing patient care through cutting-edge technologies and integrating medical imaging into everyday medical practice. With a focus on research, development, and collaboration, Intrasense SA strives to deliver high-quality products that empower healthcare providers to make accurate diagnoses and optimize treatment planning. The company's commitment to excellence, customer satisfaction, and continuous improvement sets it apart in the field of medical imaging.
Analysts currently set an average price target of 0.24 EUR for the Intrasense stock (median: 0.24 EUR), implying +19.4 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Intrasense stock: 0 recommend buying, 3 holding and 4 selling. For 2026, analysts expect Intrasense to generate revenue of 7.17 B EUR and earnings per share of -0.03 EUR.
The Intrasense share (ALINS.PA) is listed on 3 stock exchanges, including: Frankfurt (I8S.F), Paris (ALINS.PA).
Intrasense SA is a leading company in medical image processing, offering state-of-the-art software and hardware solutions for hospitals, medical practices, and clinical research facilities. The company has three main business areas: 1. Medical Imaging: Intrasense SA provides image processing solutions for medical imaging, including PACS (Picture Archiving and Communication System) and 3D imaging. The products include: - Myrian, a web-based PACS system that allows medical professionals to store, view, and share medical images from various sources. - Myrian Studio, a powerful software for the evaluation of medical images, used in clinical diagnosis, medical research, and medical imaging. 2. Cardiovascular Imaging: Intrasense SA provides specialized solutions for cardiovascular imaging. CT is one of the most important methods of modern medical diagnostics. The products include: - Myrian X-Flow, a specialized software for cardiac imaging that enables medical professionals to make precise and detailed diagnoses for heart diseases. - Myrian Vitals, a software for real-time visualization of vital parameters during medical imaging. 3. Research and Development: Intrasense SA also offers specialized software solutions for clinical research. This includes solutions for image analysis for clinical studies, analysis of large datasets, and development of algorithms for image processing. The products include: - Myrian Research, a modular toolkit for the automated analysis of medical images for clinical research. - Myrian Connect, a platform for the exchange and collaboration of researchers and professionals in the field of clinical research. Overall, Intrasense SA offers a wide range of products for medical image processing. The products are used and appreciated by medical professionals, researchers, and developers worldwide. The business model of Intrasense SA is based on a combination of software license sales, subscription models, and services. Intrasense SA earns money through the sale of software licenses and subscriptions, as well as the use of specialized expertise. Intrasense SA is committed to constantly improving existing products and developing new products and solutions to meet the needs of medical professionals and researchers. The company works closely with customers and experts to adapt its products to the needs of customers and thus build long-term business relationships. Overall, the business model of Intrasense SA is very solid and focused on innovation and customer orientation. With its state-of-the-art medical image processing products and strong customer base, Intrasense SA is well-positioned to continue growing and succeeding in the rapidly growing and rapidly changing healthcare industry.
The expected revenue of Intrasense is 7.17 B EUR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Intrasense is -1.63 M EUR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Intrasense is currently -6.63. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Intrasense stock.
The price-to-sales ratio (P/S) of Intrasense is currently 0.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Intrasense stock.
The Eulerpool Quality Score for Intrasense is 4/10.
The ISIN of Intrasense is FR0011179886. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Intrasense is A1W6V5. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Intrasense is ALINS.PA. The ticker symbol is used to trade Intrasense shares on the stock exchange.
Intrasense stock
Intrasense Peer Group
Intrasense Ticker
Intrasense FIGI
All fundamentals and in-depth analysis of Intrasense
Our stock analysis for Intrasense stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Intrasense. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.